Robert Funck

Insider profile

Performance

Overall performance
2.5

Performance over holding periods
2.5
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 88% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Vice President, Controller Abbott Laboratories Jan. 1, 2013 - Jan. 1, 2018
Compliance Officer, Vice President - Chief Ethics Abbott Laboratories Jan. 1, 2009 - Jan. 1, 2013

Robert Funck's trades of Abbott Laboratories's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
165.50
Quantity 73,977
Value US$4,636,070
Transaction date
Sale
Price
350.50
Quantity 44,528 -36.9%
Value US$3,573,924
Transaction date
Proposed sale
Price
187.84
Quantity 21,870
Value US$867,962
Transaction date
Sale
Price
100.70
Quantity 1,264 -0.6%
Value US$127,285
Transaction date
Sale
Price
108.83
Quantity 83,333 -31.4%
Value US$9,068,955
Transaction date
Sale
Price
77.89
Quantity 1,356 -0.8%
Value US$105,619
Transaction date
Sale
Price
78.00
Quantity 1,002 -0.7%
Value US$78,156
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-11-04 2024-11-04 PrS Proposed sale
73,977
165.50
US$4,636,070
73,977 165.50 US$4,636,070
2024-05-14 2024-05-10 S Sale
44,528 -36.9%
350.50
US$3,573,924
44,528 -36.9% 350.50 US$3,573,924
2024-05-10 2024-05-10 PrS Proposed sale
21,870
187.84
US$867,962
21,870 187.84 US$867,962
2023-03-02 2023-03-01 S Sale
1,264 -0.6%
100.70
US$127,285
1,264 -0.6% 100.70 US$127,285
2020-10-28 2020-10-26 S Sale
83,333 -31.4%
108.83
US$9,068,955
83,333 -31.4% 108.83 US$9,068,955
2020-03-03 2020-03-02 S Sale
1,356 -0.8%
77.89
US$105,619
1,356 -0.8% 77.89 US$105,619
2019-03-04 2019-03-01 S Sale
1,002 -0.7%
78.00
US$78,156
1,002 -0.7% 78.00 US$78,156